Efficacy of Dexmedetomidine Versus Clonidine as an Adjuvant to Bupivacaine in Epidural Anesthesia for Lower Limb Surgeries: A Clinical Assessment

Abstract

Background
Epidural anesthesia is commonly used for lower limb surgeries to provide effective intraoperative anesthesia and postoperative pain relief. Alpha two adrenergic agonists like dexmedetomidine and clonidine are often added to local anesthetics to improve the quality and duration of anesthesia. This study compares the effects of dexmedetomidine and clonidine as adjuvants to 0.5 percent bupivacaine in epidural anesthesia for lower limb surgeries.
Methods
A randomized double blind controlled study was conducted on 66 ASA I and II patients undergoing lower limb surgeries under epidural anesthesia. Patients were randomly divided into two groups. Group D received 15 ml of 0.5 percent bupivacaine with dexmedetomidine 1 microgram per kg while Group C received 15 ml of 0.5 percent bupivacaine with clonidine 2 microgram per kg. The onset and duration of sensory and motor block, sedation levels, hemodynamic stability, postoperative pain scores, and adverse effects were recorded.
Results
Dexmedetomidine resulted in faster onset and longer duration of sensory and motor block compared to clonidine. Sedation scores were significantly higher in Group D. Postoperative analgesia lasted longer with dexmedetomidine, reducing the need for additional pain relief. However, Group D had a higher incidence of bradycardia and hypotension, though both remained manageable.
Conclusion
Dexmedetomidine is a better adjuvant than clonidine for epidural bupivacaine in lower limb surgeries as it provides prolonged anesthesia, better sedation and superior postoperative pain relief. It causes more hemodynamic changes, requiring close monitoring in patients with cardiovascular risks. The choice of adjuvant should depend on individual patient needs.